How to Test for Early Menopause: FSH, AMH & More

Testing for early menopause typically involves a combination of blood tests, a review of your symptoms, and sometimes an ultrasound. The most important initial test measures follicle-stimulating hormone (FSH) in your blood, with levels above 30 U/L indicating ovarian function consistent with menopause. But a single test rarely tells the whole story, and your doctor will also need to rule out other conditions that can mimic early menopause before confirming a diagnosis.

Early menopause refers to menopause occurring between ages 40 and 45. When it happens before age 40, it’s called premature menopause or primary ovarian insufficiency (POI). Natural menopause is officially defined as 12 consecutive months without a period, with no other medical explanation. But if you’re younger than 45 and noticing changes, you don’t have to wait a full year before getting tested.

Symptoms That Warrant Testing

The most common early signal is a shift in your menstrual cycle. Your periods may come closer together or further apart, last fewer days, or become noticeably lighter or heavier than usual. Missing a few periods doesn’t automatically mean early menopause, but it’s worth investigating if you’re under 45 and don’t have another explanation like pregnancy.

Hot flashes are the hallmark symptom of menopause at any age. You might also notice trouble sleeping, vaginal dryness or pain during sex, and urinary changes like increased frequency or urgency. Some women experience mood shifts, difficulty concentrating, or joint stiffness. None of these symptoms alone confirms early menopause, but a cluster of them alongside irregular periods is a strong reason to get tested.

The FSH Blood Test

FSH is the first-line blood test for evaluating menopause. This hormone signals your ovaries to produce eggs each month. When your ovaries start running low on eggs, your brain compensates by producing more FSH, essentially shouting louder at ovaries that aren’t responding. A level above 30 U/L indicates a degree of ovarian insufficiency consistent with perimenopause or menopause, and in many clinical settings, a single elevated result is enough to confirm the picture without repeating the test.

A result below 30 U/L does not rule out perimenopause. FSH levels can swing wildly during the transition, testing high one month and normal the next. If your result comes back below the threshold but your symptoms are suggestive, your doctor will likely recheck in 6 to 12 months. For the most accurate reading, blood is ideally drawn early in your menstrual cycle (around days 2 to 5), when FSH levels are at their baseline. If your periods have already stopped, the test can be done on any day.

Estradiol Levels

Estradiol is the primary form of estrogen your ovaries produce. Your doctor may order this test alongside FSH to get a fuller picture. In postmenopausal women, estradiol typically drops below 10 pg/mL. Low estradiol combined with high FSH strengthens the case for ovarian failure. On its own, low estradiol can also result from significant weight loss, eating disorders, or excessive exercise, so it’s always interpreted alongside other results.

AMH Testing for Ovarian Reserve

Anti-Müllerian hormone (AMH) is produced by the small follicles in your ovaries and serves as a snapshot of your remaining egg supply. Unlike FSH, AMH levels stay relatively stable throughout your menstrual cycle, so the blood draw doesn’t need to be timed to a specific day.

AMH is especially useful for women under 40 who are concerned about premature menopause. Research published in The Journal of Clinical Endocrinology and Metabolism found that women with an AMH level of 0.5 ng/mL had 23 times the odds of experiencing early menopause compared to women with a level of 2.0 ng/mL. When AMH drops to very low or undetectable levels in women under 48, there’s roughly a 50% chance of reaching your final period within a year and a 78% chance within three years. This makes AMH one of the better tools for predicting how close menopause might be, not just confirming it after the fact.

Ultrasound: Antral Follicle Count

A transvaginal ultrasound can directly count the small follicles (measuring 2 to 10 millimeters) visible on both ovaries. This number, called the antral follicle count (AFC), gives a real-time estimate of ovarian reserve. A count of 4 or fewer follicles across both ovaries is a meaningful marker. In the CARDIA Women’s Study, women with an AFC of 4 or fewer were nearly twice as likely to reach menopause over the following seven years compared to women with higher counts.

Ultrasound isn’t always part of the initial workup. It’s more commonly used when blood tests are inconclusive or when fertility preservation is a concern. The procedure takes about 10 minutes and isn’t painful, though it can be mildly uncomfortable.

Ruling Out Other Causes

Several conditions can stop your periods or cause symptoms that look identical to early menopause, and your doctor needs to exclude them before making a diagnosis. The two most important are thyroid dysfunction and elevated prolactin levels.

An underactive or overactive thyroid can disrupt your menstrual cycle, cause fatigue, mood changes, and weight shifts. A simple TSH blood test checks for this. Prolactin, the hormone involved in milk production, can become elevated due to thyroid problems, certain medications, or benign pituitary growths. High prolactin suppresses ovulation and stops periods. Both thyroid and prolactin testing are standard parts of the workup when a woman presents with missed periods, and they’re done with the same blood draw as your FSH and estradiol.

Your doctor will also consider pregnancy (even if you think it’s unlikely), polycystic ovary syndrome, extreme stress, and significant changes in weight or exercise habits as potential explanations before attributing missed periods to early menopause.

Genetic Testing

If you’re diagnosed with premature menopause before age 40, your doctor may recommend genetic screening. The most established link is with the FMR1 gene, which carries the premutation associated with Fragile X syndrome. Women who carry this premutation face a higher risk of primary ovarian insufficiency and may experience earlier cessation of periods and reduced fertility. Carriers should be informed about both their reproductive timeline and the possibility of passing Fragile X to children.

Karyotype analysis, which examines your chromosomes, is sometimes ordered as well. Certain chromosomal patterns, particularly involving the X chromosome, can cause the ovaries to fail earlier than expected. Genetic testing is not routine for women who reach menopause between 40 and 45, but it becomes more relevant the younger you are at diagnosis or if there’s a family history of early menopause or Fragile X.

What the Testing Timeline Looks Like

Most of the initial testing happens in a single appointment. Your doctor will draw blood for FSH, estradiol, thyroid function, and prolactin, and may add AMH if early menopause is suspected. Results typically come back within a few days. If FSH is elevated above 30 U/L and other causes have been excluded, many clinicians will confirm the diagnosis without further testing.

If results are ambiguous, you’ll likely be asked to return in one to three months for repeat testing. The fluctuating nature of hormones during perimenopause means a single snapshot can be misleading. For women still having occasional periods, timing the blood draw to the early days of a cycle improves accuracy. If you’re on hormonal birth control, your doctor may ask you to stop it temporarily before testing, since the pill suppresses your natural hormone levels and can mask what’s actually happening with your ovaries.

An ultrasound for antral follicle count may be scheduled separately if blood results suggest diminished ovarian reserve or if you’re interested in fertility options. Genetic testing, when indicated, involves a separate blood draw and results can take several weeks.